Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiwon Oh

Showing results (211-220 of 267) with videos related to

Pageof 27
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 22, 2015
Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and MonitoringAnthony Traboulsee, Laurent Létourneau-Guillon, Mark Steven Freedman, et al.
Environment International|September 6, 2025
Prenatal exposure to per- and polyfluoroalkyl substances: Association with child behavior in the environmental influences on child health outcomes (ECHO) CohortCatherine M Bulka, Lesliam Quiros-Alcala, Xiaoshuang Xun, et al.
JAMA Neurology|January 16, 2013
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosisShiv Saidha, Elias S Sotirchos, Jiwon Oh, et al.
Environmental Pollution (Barking, Essex : 1987)|November 27, 2025
Psychosocial stressors as modifiers of the associations between well-studied and understudied chemicals and birth outcomes in the ECHO CohortStephanie M Eick, Patricia A Brennan, Jessie P Buckley, et al.
Brain : a Journal of Neurology|January 16, 2024
Imaging chronic active lesions in multiple sclerosis: a consensus statementFrancesca Bagnato, Pascal Sati, Christopher C Hemond, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
Magnetic Resonance in Medicine|June 16, 2017
Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T<sub>1</sub> -weighted brain MRI acquisitionsNico Papinutto, Rohit Bakshi, Antje Bischof, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 18, 2020
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain AtrophyFrancesca Bagnato, Susan A Gauthier, Cornelia Laule, et al.
Environmental Science & Technology|May 14, 2026
Prenatal Exposure to Nitrogen Dioxide, Fine Particulates, and Ozone in Relation to Child Behavior: The Environmental Influences on Child Health Outcomes CohortJiwon Oh, Akhgar Ghassabian, Judy Aschner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2023
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 studyBarry A Singer, Douglas L Arnold, Jelena Drulovic, et al.
Pageof 27

Showing results (211-220 of 267) with videos related to

Sort By:
Pageof 27
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 22, 2015
Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and MonitoringAnthony Traboulsee, Laurent Létourneau-Guillon, Mark Steven Freedman, et al.
Environment International|September 6, 2025
Prenatal exposure to per- and polyfluoroalkyl substances: Association with child behavior in the environmental influences on child health outcomes (ECHO) CohortCatherine M Bulka, Lesliam Quiros-Alcala, Xiaoshuang Xun, et al.
JAMA Neurology|January 16, 2013
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosisShiv Saidha, Elias S Sotirchos, Jiwon Oh, et al.
Environmental Pollution (Barking, Essex : 1987)|November 27, 2025
Psychosocial stressors as modifiers of the associations between well-studied and understudied chemicals and birth outcomes in the ECHO CohortStephanie M Eick, Patricia A Brennan, Jessie P Buckley, et al.
Brain : a Journal of Neurology|January 16, 2024
Imaging chronic active lesions in multiple sclerosis: a consensus statementFrancesca Bagnato, Pascal Sati, Christopher C Hemond, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
Magnetic Resonance in Medicine|June 16, 2017
Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T<sub>1</sub> -weighted brain MRI acquisitionsNico Papinutto, Rohit Bakshi, Antje Bischof, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 18, 2020
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain AtrophyFrancesca Bagnato, Susan A Gauthier, Cornelia Laule, et al.
Environmental Science & Technology|May 14, 2026
Prenatal Exposure to Nitrogen Dioxide, Fine Particulates, and Ozone in Relation to Child Behavior: The Environmental Influences on Child Health Outcomes CohortJiwon Oh, Akhgar Ghassabian, Judy Aschner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2023
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 studyBarry A Singer, Douglas L Arnold, Jelena Drulovic, et al.
Pageof 27